PAVmed PAVM Stock
PAVmed Price Chart
PAVmed PAVM Financial and Trading Overview
| PAVmed stock price | 6.04 USD |
| Previous Close | 5.53 USD |
| Open | 5.46 USD |
| Bid | 3.86 USD x 200 |
| Ask | 7.21 USD x 200 |
| Day's Range | 5.46 - 5.46 USD |
| 52 Week Range | 3.85 - 28.44 USD |
| Volume | 2.3K USD |
| Avg. Volume | 17.93K USD |
| Market Cap | 39.09M USD |
| Beta (5Y Monthly) | 0.548 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -48.31 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 36 USD |
PAVM Valuation Measures
| Enterprise Value | 38.77M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.2285714 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 459.86264 |
| Price/Book (mrq) | 0.9570552 |
| Enterprise Value/Revenue | 456.09 |
| Enterprise Value/EBITDA | -1.595 |
Trading Information
PAVmed Stock Price History
| Beta (5Y Monthly) | 0.548 |
| 52-Week Change | -68.0046% |
| S&P500 52-Week Change | 20.36% |
| 52 Week High | 28.44 USD |
| 52 Week Low | 3.85 USD |
| 50-Day Moving Average | 5.93 USD |
| 200-Day Moving Average | 9.28 USD |
PAVM Share Statistics
| Avg. Volume (3 month) | 17.93K USD |
| Avg. Daily Volume (10-Days) | 15.75K USD |
| Shares Outstanding | 7.16M |
| Float | 5.2M |
| Short Ratio | 1.29 |
| % Held by Insiders | 44.14% |
| % Held by Institutions | 27.52% |
| Shares Short | 33.65K |
| Short % of Float | 0.64% |
| Short % of Shares Outstanding | 0.47% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -36522.72% |
| Gross Margin | -228.23% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -31.039% |
| Return on Equity (ttm) | -67.22% |
Income Statement
| Revenue (ttm) | 85K USD |
| Revenue Per Share (ttm) | 0.09 USD |
| Quarterly Revenue Growth (yoy) | 175.00% |
| Gross Profit (ttm) | -194000 USD |
| EBITDA | -24313000 USD |
| Net Income Avi to Common (ttm) | -28457000 USD |
| Diluted EPS (ttm) | -48.31 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.84M USD |
| Total Cash Per Share (mrq) | 0.96 USD |
| Total Debt (mrq) | 17.01M USD |
| Total Debt/Equity (mrq) | 68.07 USD |
| Current Ratio (mrq) | 2.023 |
| Book Value Per Share (mrq) | 5.705 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6245000 USD |
| Levered Free Cash Flow (ttm) | -11418375 USD |
Profile of PAVmed
| Country | United States |
| State | NY |
| City | New York |
| Address | 360 Madison Avenue |
| ZIP | 10017 |
| Phone | 917 813 1828 |
| Website | https://www.pavmed.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 41 |
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck device. Its product pipeline also comprises EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
Q&A For PAVmed Stock
What is a current PAVM stock price?
PAVmed PAVM stock price today per share is 6.04 USD.
How to purchase PAVmed stock?
You can buy PAVM shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PAVmed?
The stock symbol or ticker of PAVmed is PAVM.
Which industry does the PAVmed company belong to?
The PAVmed industry is Medical Devices.
How many shares does PAVmed have in circulation?
The max supply of PAVmed shares is 7.16M.
What is PAVmed Price to Earnings Ratio (PE Ratio)?
PAVmed PE Ratio is now.
What was PAVmed earnings per share over the trailing 12 months (TTM)?
PAVmed EPS is -48.31 USD over the trailing 12 months.
Which sector does the PAVmed company belong to?
The PAVmed sector is Healthcare.
PAVmed PAVM included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26210.68 USD — |
+0.4
|
2.18B USD — | 26129.08 USD — | 26316.81 USD — | — - | 2.18B USD — |
|
US Tech Capital Market Composite
RCMP
US
|
140.02 USD — |
-0.2
|
— — | 139.79 USD — | 141.42 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1248.5 USD — |
+0.58
|
— — | 1233.72 USD — | 1249.12 USD — | — - | — — |
- {{ link.label }} {{link}}